PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma

References

• Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149(5):541–11. doi:10.1001/jamadermatol.2013.2139.
   PubMed Web of Science ®Google Scholar
• Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–720. doi:10.1016/S1470-2045(08)70178-5.
   PubMed Web of Science ®Google Scholar
• Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65(1):185–202. doi:10.1146/annurev-med-092012-112807.
   PubMedGoogle Scholar
• Ribas A. Releasing the Brakes on Cancer Immunotherapy. N Engl J Med. 2015;373(16):1490–1492. doi:10.1056/NEJMp1510079.
   PubMed Web of Science ®Google Scholar
• Grob JJ, Gonzalez R, Basset-Seguin N, Vornicova O, Schachter J, Joshi A, Meyer N, Grange F, Piulats JM, Bauman JR, et al. Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: a Single-Arm Phase II Trial (KEYNOTE-629. J Clin Oncol. 2020;38(25):2916–2925. doi:10.1200/JCO.19.03054.
   PubMed Web of Science ®Google Scholar
• Kubli SP, Berger T, Araujo DV, Siu LL, Mak TW. Beyond immune checkpoint blockade: emerging immunological strategies. Nat Rev Drug Discov. 2021 Dec;20(12):899–919. doi:10.1038/s41573-021-00155-y. PMID: 33686237.
   PubMed Web of Science ®Google Scholar
• Skaria AM. European guidelines for topical PDT part 1 JEADV. J Eur Acad Dermatol Venereol. 2013;28(5):673. doi:10.1111/jdv.12258.
   PubMed Web of Science ®Google Scholar
• Cohen DK, Lee PK. Photodynamic therapy for non-melanoma skin cancers. Cancers (Basel). 2016;8(10):90. doi:10.3390/cancers8100090.
   PubMed Web of Science ®Google Scholar
• Zhang GL, Keyal U, Shi L, Wang PR, Zhang LL, Bhatta AK, Wu YH, Fang S, Wang XL. Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: single center experience. Photodiagnosis Photodyn Ther. 2020;32:101980. doi:10.1016/j.pdpdt.2020.101980.
   PubMed Web of Science ®Google Scholar
• Keyal U, Bhatta AK, Zhang G, Wang XL. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2019;80(3):765–773. doi:10.1016/j.jaad.2018.10.042.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Zhang G, Zhou Z, Zhang H, Zhao Z, Shi L, Wang X. Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: case experience. Photodiagnosis Photodyn Ther. 2018;21:393–395. doi:10.1016/j.pdpdt.2017.12.010.
   PubMed Web of Science ®Google Scholar
• Gilaberte Y, Milla L, Salazar N, Vera-Alvarez J, Kourani O, Damian A, Rivarola V, Roca MJ, Espada J, Gonzalez S, et al. Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy. J Invest Dermatol. 2014;134(9):2428–2437. doi:10.1038/jid.2014.178.
   PubMed Web of Science ®Google Scholar
• Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347:f6153. doi:10.1136/bmj.f6153.
   PubMed Web of Science ®Google Scholar
• Ji J, Zhang Y, Chen WR, Wang X. DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinoma. Oncoimmunology. 2016;5(6):e1072674. doi:10.1080/2162402X.2015.1072674.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang H, Zeng Q, Wang P, Zhang G, Ji J, Li M, Shen S, Wang X. Exosomes from 5-aminolevulinic acid photodynamic therapy-treated squamous carcinoma cells promote dendritic cell maturation. Photodiagnosis Photodyn Ther. 2020;30:101746. doi:10.1016/j.pdpdt.2020.101746.
   PubMed Web of Science ®Google Scholar
• Gomes-da-silva LC, Zhao L, Arnaut LG, Kroemer G, Kepp O. Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus. Oncotarget. 2018;9(58):31169–31170. doi:10.18632/oncotarget.25798.
   PubMedGoogle Scholar
• Gomes-da-silva LC, Zhao L, Bezu L, Zhou H, Sauvat A, Liu P, Durand S, Leduc M, Souquere S, Loos F, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. EMBO J. 2018;37. doi:10.15252/embj.201798354.
   PubMed Web of Science ®Google Scholar
• Panzarini E, Inguscio V, Fimia GM, Dini L. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells. PLoS One. 2014;9:e105778. doi:10.1371/journal.pone.0105778.
   PubMed Web of Science ®Google Scholar
• Turubanova VD, Balalaeva IV, Mishchenko TA, Catanzaro E, Alzeibak R, Peskova NN, Efimova I, Bachert C, Mitroshina EV, Krysko O, et al. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. J Immunother Cancer. 2019;7(1):350. doi:10.1186/s40425-019-0826-3.
   PubMed Web of Science ®Google Scholar
• Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307–325. doi:10.1038/s41568-019-0144-6.
   PubMed Web of Science ®Google Scholar
• Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Sautes-Fridman C. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev. 2016;271:260–275. doi:10.1111/imr.12405.
   PubMed Web of Science ®Google Scholar
• Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549–555.
   PubMed Web of Science ®Google Scholar
• Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561–565.
   PubMed Web of Science ®Google Scholar
• Petitprez F, de Reynies A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougouin A, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577:556–560. doi:10.1038/s41586-019-1906-8.
   PubMed Web of Science ®Google Scholar
• Wang X, Shi L, Tu Q, Wang H, Zhang H, Wang P, Zhang L, Huang Z, Zhao F, Luan H, et al. Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model. Int J Nanomedicine. 2015;10:347–355. doi:10.2147/IJN.S71245.
   PubMed Web of Science ®Google Scholar
• Zhang G, Yan G, Fu Z, Wu Y, Wu F, Zheng Z, Fang S, Gao Y, Bao X, Liu Y, et al. Loss of retinoic acid receptor-related receptor alpha (Roralpha) promotes the progression of UV-induced cSCC. Cell Death Dis. 2021;12:247. doi:10.1038/s41419-021-03525-x.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Zhang H, Qin J, Xu Z, Gui L, Liu B, Liu C, Xu C, Liu W, Zhang S, et al. Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell Mol Life Sci. 2015;72:4867–4884. doi:10.1007/s00018-015-1976-1.
   PubMed Web of Science ®Google Scholar
• Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018;78:237–247. doi:10.1016/j.jaad.2017.08.059.
   PubMed Web of Science ®Google Scholar
• Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K. Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging Dis. 2017;8:643–661. doi:10.14336/AD.2017.0503.
   PubMed Web of Science ®Google Scholar
• Mishchenko TA, Balalaeva IV, Vedunova MV, Krysko DV. Ferroptosis and photodynamic therapy synergism: enhancing anticancer treatment. Trends Cancer. 2021;7:484–487. doi:10.1016/j.trecan.2021.01.013.
   PubMed Web of Science ®Google Scholar
• Aaes TL, Verschuere H, Kaczmarek A, Heyndrickx L, Wiernicki B, Delrue I, De Craene B, Taminau J, Delvaeye T, Bertrand MJM, et al. Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection. J Immunol. 2020;204:775–787. doi:10.4049/jimmunol.1900072.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8:e000337. doi:10.1136/jitc-2019-000337.
   PubMed Web of Science ®Google Scholar
• Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 2011;71:5678–5687. doi:10.1158/0008-5472.CAN-11-0431.
   PubMed Web of Science ®Google Scholar
• Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189:832–844. doi:10.1164/rccm.201309-1611OC.
   PubMed Web of Science ®Google Scholar
• Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS, Mule JJ. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep. 2012;2:765. doi:10.1038/srep00765.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hu Y, Wang H. Targeting antitumor immune response for enhancing the efficacy of photodynamic therapy of cancer: recent advances and future perspectives. Oxid Med Cell Longev. 2016;2016:5274084. doi:10.1155/2016/5274084.
   PubMed Web of Science ®Google Scholar
• Maeding N, Verwanger T, Krammer B. Boosting Tumor-Specific Immunity Using PDT. Cancers (Basel). 2016;8(10):91. doi:10.3390/cancers8100091.
   PubMed Web of Science ®Google Scholar
• Hwang HS, Shin H, Han J, Na K. Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig. 2018;48(2):143–151. doi:10.1007/s40005-017-0377-x.
   PubMedGoogle Scholar
• Kaleta-Richter M, Kawczyk-Krupka A, Aebisher D, Bartusik-Aebisher D, Czuba Z, Cieslar G. The capability and potential of new forms of personalized colon cancer treatment: immunotherapy and photodynamic therapy. Photodiagnosis Photodyn Ther. 2019;25:253–258. doi:10.1016/j.pdpdt.2019.01.004.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Fan G, Wu H, Liu C, Zhan Y, Qiu Y, Shou C, Gao F, Zhang J, Yin P, et al. Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles. Mol Ther. 2021;29(10):2931–2948. doi:10.1016/j.ymthe.2021.05.017.
   PubMed Web of Science ®Google Scholar
• Liu Y, Pan Y, Cao W, Xia F, Liu B, Niu J, Alfranca G, Sun X, Ma L, de la Fuente JM, et al. A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy. Theranostics. 2019;9:6867–6884. doi:10.7150/thno.37586.
   PubMed Web of Science ®Google Scholar
• Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9(12):1673–1685. doi:10.1158/2159-8290.CD-19-0338.
   PubMed Web of Science ®Google Scholar
• Ji J, Fan Z, Zhou F, Wang X, Shi L, Zhang H, Wang P, Yang D, Zhang L, Chen WR, et al. Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma. Oncotarget. 2015;6(19):17135–17146. doi:10.18632/oncotarget.3529.
   PubMedGoogle Scholar